NASDAQ : NMTC
NeuroOne Medical Technologies Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 0.9272 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 8.44M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 8.44M |
| Enterprise Value | 6.57M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 9.11M |
| Shares Outstanding | 9.11M |
| Shares Change (YoY) | +44.82% |
| Shares Change (QoQ) | +3.00% |
| Owned by Insiders (%) | 31.22% |
| Owned by Institutions (%) | 29.73% |
| Float | 6.26M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.68 |
| Forward PS | 0.64 |
| PB Ratio | 2.14 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.84 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -124.66% |
| Return on Assets (ROA) | -58.07% |
| Return on Invested Capital (ROIC) | -79.53% |
| Return on Capital Employed (ROCE) | -190.60% |
| Weighted Average Cost of Capital (WACC) | 9.01% |
| Revenue Per Employee | $692,706 |
| Profits Per Employee | -$413,637 |
| Employee Count | 18 |
| Asset Turnover | 1.47 |
| Inventory Turnover | 4.58 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -80.33% |
| 50-Day Moving Average | 1.32 |
| 200-Day Moving Average | 3.20 |
| Relative Strength Index (RSI) | 39.95 |
| Average Volume (20 Days) | 149,345 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 207,315 |
| Short Previous Month | 178,730 |
| Short % of Shares Out | 2.28% |
| Short % of Float | 3.31% |
| Short Ratio (days to cover) | 1.17 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 12.47M |
| Gross Profit | 2.87M |
| Operating Income | -7.90M |
| Pretax Income | -7.45M |
| Net Income | -7.45M |
| EBITDA | -7.66M |
| EBIT | -7.90M |
| Loss Per Share | -$0.95 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.05M |
| Total Debt | 175,345 |
| Net Cash | 1.87M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 3.77M |
| Book Value Per Share | 0.43 |
| Working Capital | 3.75M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.05M |
| Capital Expenditures | -109,536 |
| Depreciation & Amortization | 236,878 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.16M |
| FCF Per Share | -$0.79 |
Margins
| Measure | Value |
|---|
| Gross Margin | 23.00% |
| Operating Margin | -63.36% |
| Pretax Margin | -59.71% |
| Profit Margin | -59.71% |
| EBITDA Margin | -61.46% |
| EBIT Margin | -63.36% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -44.82% |
| Shareholder Yield | n/a |
| Earnings Yield | -102.88% |
| FCF Yield | -84.82% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $7.27 |
| Price Target Difference | 684.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 20.11% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 16, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -11.03 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |